Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$98.98 - $115.74 $697,017 - $815,041
-7,042 Reduced 0.89%
786,313 $91 Million
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $17.4 Million - $20.3 Million
-180,400 Reduced 18.53%
793,355 $81.6 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $10.7 Million - $11.3 Million
99,464 Added 11.38%
973,755 $106 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $10.1 Million - $18.4 Million
161,730 Added 22.7%
874,291 $99.5 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $13.3 Million - $19.1 Million
225,900 Added 46.42%
712,561 $44.1 Million
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $38.6 Million - $56.6 Million
486,661 New
486,661 $38.8 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.